Advanced technology aids discovery of diabetic retinopathy, with more eye disease to follow.
This article discusses the current use of artificial intelligence in ophthalmology, particularly for diagnosing diabetic retinopathy, highlighting FDA-approved devices used in primary care and anticipating future applications beyond diabetic retinopathy.